Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial

Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial

Rationale The blood–brain barrier (BBB) largely restricts the efficacy of neuroprotectants, which is an important approach in treating large hemispheric infarction (LHI). In this study, we harnessed intracalvariosseous (ICO) injection to bypass the BBB and facilitate drug delivery.Aim To compare the...

Full description

Saved in:
Bibliographic Details
Main Authors: Yongjun Wang, Yilong Wang, Yuesong Pan, Mo Yang, Xuan Wang, Mengyuan Zhou, Weiming Liu, Zhiwei Sun, Meiyang Zhang, Nanxing Wang, Wenqian Liu, Yunwei Ou
Format: Article
Language:English
Published: BMJ Publishing Group
Series:Stroke and Vascular Neurology
Online Access:https://svn.bmj.com/content/early/2025/06/02/svn-2024-004011.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://svn.bmj.com/content/early/2025/06/02/svn-2024-004011.full

Similar Items